These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 24148123)
21. Activation of heterotrimeric G proteins by Smoothened. Riobo NA; Saucy B; Dilizio C; Manning DR Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12607-12. PubMed ID: 16885213 [TBL] [Abstract][Full Text] [Related]
22. Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant. Ishii T; Shimizu Y; Nakashima K; Kondo S; Ogawa K; Sasaki S; Matsui H Eur J Pharmacol; 2014 Jan; 723():305-13. PubMed ID: 24291104 [TBL] [Abstract][Full Text] [Related]
23. Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonists. Lucas BS; Aaron W; An S; Austin RJ; Brown M; Chan H; Chong A; Hungate R; Huang T; Jiang B; Johnson MG; Kaizerman JA; Lee G; McMinn DL; Orf J; Powers JP; Rong M; Toteva MM; Uyeda C; Wickramasinghe D; Xu G; Ye Q; Zhong W Bioorg Med Chem Lett; 2010 Jun; 20(12):3618-22. PubMed ID: 20493695 [TBL] [Abstract][Full Text] [Related]
24. GDC-0449--targeting the hedgehog signaling pathway. Dierks C Recent Results Cancer Res; 2010; 184():235-8. PubMed ID: 20072843 [TBL] [Abstract][Full Text] [Related]
25. The Hedgehog pathway effector smoothened exhibits signaling competency in the absence of ciliary accumulation. Fan CW; Chen B; Franco I; Lu J; Shi H; Wei S; Wang C; Wu X; Tang W; Roth MG; Williams NS; Hirsch E; Chen C; Lum L Chem Biol; 2014 Dec; 21(12):1680-9. PubMed ID: 25484239 [TBL] [Abstract][Full Text] [Related]
26. Reduced level of smoothened suppresses intestinal tumorigenesis by down-regulation of Wnt signaling. Arimura S; Matsunaga A; Kitamura T; Aoki K; Aoki M; Taketo MM Gastroenterology; 2009 Aug; 137(2):629-38. PubMed ID: 19427313 [TBL] [Abstract][Full Text] [Related]
27. Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer. Yun JI; Kim HR; Park H; Kim SK; Lee J Arch Pharm Res; 2012 Aug; 35(8):1317-33. PubMed ID: 22941475 [TBL] [Abstract][Full Text] [Related]
29. A paracrine requirement for hedgehog signalling in cancer. Yauch RL; Gould SE; Scales SJ; Tang T; Tian H; Ahn CP; Marshall D; Fu L; Januario T; Kallop D; Nannini-Pepe M; Kotkow K; Marsters JC; Rubin LL; de Sauvage FJ Nature; 2008 Sep; 455(7211):406-10. PubMed ID: 18754008 [TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of Hedgehog modulator properties after functional coupling of Smoothened to G15. Masdeu C; Faure H; Coulombe J; Schoenfelder A; Mann A; Brabet I; Pin JP; Traiffort E; Ruat M Biochem Biophys Res Commun; 2006 Oct; 349(2):471-9. PubMed ID: 16945339 [TBL] [Abstract][Full Text] [Related]
31. Vismodegib, a small-molecule inhibitor of the hedgehog pathway for the treatment of advanced cancers. De Smaele E; Ferretti E; Gulino A Curr Opin Investig Drugs; 2010 Jun; 11(6):707-18. PubMed ID: 20496266 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts. Walter K; Omura N; Hong SM; Griffith M; Vincent A; Borges M; Goggins M Clin Cancer Res; 2010 Mar; 16(6):1781-9. PubMed ID: 20215540 [TBL] [Abstract][Full Text] [Related]
34. Stability study of the human G-protein coupled receptor, Smoothened. Nehmé R; Joubert O; Bidet M; Lacombe B; Polidori A; Pucci B; Mus-Veteau I Biochim Biophys Acta; 2010 Jun; 1798(6):1100-10. PubMed ID: 20188061 [TBL] [Abstract][Full Text] [Related]
35. N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists. Muraglia E; Ontoria JM; Branca D; Dessole G; Bresciani A; Fonsi M; Giuliano C; Llauger Bufi L; Monteagudo E; Palumbi MC; Torrisi C; Rowley M; Steinkühler C; Jones P Bioorg Med Chem Lett; 2011 Sep; 21(18):5283-8. PubMed ID: 21802943 [TBL] [Abstract][Full Text] [Related]
36. Crystal structure of a multi-domain human smoothened receptor in complex with a super stabilizing ligand. Zhang X; Zhao F; Wu Y; Yang J; Han GW; Zhao S; Ishchenko A; Ye L; Lin X; Ding K; Dharmarajan V; Griffin PR; Gati C; Nelson G; Hunter MS; Hanson MA; Cherezov V; Stevens RC; Tan W; Tao H; Xu F Nat Commun; 2017 May; 8():15383. PubMed ID: 28513578 [TBL] [Abstract][Full Text] [Related]
37. International Union of Basic and Clinical Pharmacology CXV: The Class F of G Protein-Coupled Receptors. Schulte G Pharmacol Rev; 2024 Oct; 76(6):1009-1037. PubMed ID: 38955509 [TBL] [Abstract][Full Text] [Related]
38. Potential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancer. Chen KC; Sun MF; Chen HY; Lee CC; Chen CY Biomed Res Int; 2014; 2014():873010. PubMed ID: 25136636 [TBL] [Abstract][Full Text] [Related]
39. Structural analogues of smoothened intracellular loops as potent inhibitors of Hedgehog pathway and cancer cell growth. Remsberg JR; Lou H; Tarasov SG; Dean M; Tarasova NI J Med Chem; 2007 Sep; 50(18):4534-8. PubMed ID: 17685505 [TBL] [Abstract][Full Text] [Related]
40. Homing in on new cancer drug targets? Senior K Lancet Oncol; 2013 Feb; 14(2):e49. PubMed ID: 23487851 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]